The treatment for Polycythemia is generally dependent on the cause.
Polycythemia defines the overproduction of red blood cells in the body.
In Polycythemia vera or other primary Polycythemia syndromes, the treatment options are more specific.
Polycythemia is a lifelong condition that has no cure
but can be managed with medication.
Patients with Polycythemia produce increased red blood cells,
which puts them at increased blood clot and pulmonary embolism risk.
Because Polycythemia vera(PV) is a rare type of blood cancer,
a diagnosis often comes when you see your doctor for other reasons.
Aspirin and other anti-platelet agents(dipyridamole[Persantine])
may also be beneficial in patients with Polycythemia by reducing clotting complications,
unless the patient has a history of bleeding problems.
All the red blood cells will clump together and block tiny blood vessels(capillaries) if
the count of RBC is too high(a condition called Polycythemia or heart disease).
In order to give greater medical attention to these- as in Polycythemia vera- often life-threatening illnesses(orphan= "orphan"),
the orphan drug status ensures far-reaching support and regulatory approval for manufacturers of suitable drugs.